Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Long-Term Debt Repayments (2023 - 2024)

Inmune Bio's Long-Term Debt Repayments history spans 2 years, with the latest figure at $2.5 million for Q4 2024.

  • For Q4 2024, Long-Term Debt Repayments changed 0.0% year-over-year to $2.5 million; the TTM value through Dec 2024 reached $10.0 million, changed N/A, while the annual FY2024 figure was $10.0 million, 100.0% up from the prior year.
  • Long-Term Debt Repayments for Q4 2024 was $2.5 million at Inmune Bio, roughly flat from $2.5 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.5 million in Q4 2023 and bottomed at $2.5 million in Q4 2023.